4
Changes in Ownership
Bionano Genomics, Inc. Filed Acc 0001209191-21-024792
Options or other derivatives
- Chief Medical Officer acquired 275,000 shares (grant or award)
From the SEC's structured data for this filing
Bionano Genomics, Inc. Filed Acc 0001209191-21-024792
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…